Veit Bücklein, Dr Med, on Looking Closer Into Differences in Response, Hematotoxicity After CAR T
January 9th 2024The postdoctoral researcher at Laboratory for Translational Cancer Immunology, Ludwig-Maximilians-Universität München, discussed further research his group is conducting with cell therapy.
Continued Research on Exa-cel and Lovo-cel Remains Important After FDA Approval
January 9th 2024Alexis Thompson, MD, MPH, the chief of hematology at Children’s Hospital of Philadelphia, discussed the need to determine whether the recently approved sickle cell disease gene therapies could benefit younger patients.